The molecular classification of BC is based on the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), resulting in four main subtypes which are luminal A, luminal B, HER2-positive (HER2+), and triple-negative breast cancer (TNBC). This evidence concerns the gene PGR and breast cancer.